1. Home
  2. MREO vs TTSH Comparison

MREO vs TTSH Comparison

Compare MREO & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MREO
  • TTSH
  • Stock Information
  • Founded
  • MREO 2015
  • TTSH 1985
  • Country
  • MREO United Kingdom
  • TTSH United States
  • Employees
  • MREO N/A
  • TTSH N/A
  • Industry
  • MREO Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • MREO Health Care
  • TTSH Finance
  • Exchange
  • MREO Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • MREO 311.8M
  • TTSH 264.5M
  • IPO Year
  • MREO N/A
  • TTSH N/A
  • Fundamental
  • Price
  • MREO $2.16
  • TTSH $6.30
  • Analyst Decision
  • MREO Strong Buy
  • TTSH
  • Analyst Count
  • MREO 5
  • TTSH 0
  • Target Price
  • MREO $7.40
  • TTSH N/A
  • AVG Volume (30 Days)
  • MREO 1.4M
  • TTSH 177.5K
  • Earning Date
  • MREO 11-11-2025
  • TTSH 11-06-2025
  • Dividend Yield
  • MREO N/A
  • TTSH N/A
  • EPS Growth
  • MREO N/A
  • TTSH N/A
  • EPS
  • MREO N/A
  • TTSH N/A
  • Revenue
  • MREO $500,000.00
  • TTSH $340,228,000.00
  • Revenue This Year
  • MREO N/A
  • TTSH N/A
  • Revenue Next Year
  • MREO $72.16
  • TTSH N/A
  • P/E Ratio
  • MREO N/A
  • TTSH N/A
  • Revenue Growth
  • MREO N/A
  • TTSH N/A
  • 52 Week Low
  • MREO $1.47
  • TTSH $4.62
  • 52 Week High
  • MREO $4.72
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • MREO 61.75
  • TTSH 51.91
  • Support Level
  • MREO $1.94
  • TTSH $6.17
  • Resistance Level
  • MREO $2.28
  • TTSH $6.39
  • Average True Range (ATR)
  • MREO 0.12
  • TTSH 0.22
  • MACD
  • MREO 0.01
  • TTSH 0.02
  • Stochastic Oscillator
  • MREO 65.53
  • TTSH 75.76

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: